NASDAQ · CLOV

Clover Health Investments, Corp.

$4.32 -$0.23 (-5.05%) 1D After hours

Key Metrics

$2.40B
Market cap
P/E · TTM
$2.21B
Revenue · TTM
−$56.94M
Net income
EPS · TTM $-0.11
Dividend yield
Free cash flow $54.54M
Beta · 1Y 1.19
EBITDA · TTM −$58.77M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 17
    A material event was filed (Form 8-K).

    8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 10
    The stock moved +14.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 10
  • May 28
    The stock moved +16.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 28
  • Apr 1
    From its Jan 29 high, the share price fell 25%.

    Peak close $2.27 on Jan 29; trough close $1.70 on Apr 1. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -25%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.40B
Enterprise value
Shares outstanding526.7M
52-wk range$1.58 – $5.59
Avg volume · 20D11.7M
Net cash
Book value / share$0.68
IndustryHospital & Medical Service Plans
ExchangeNASDAQ
About Clover Health Investments, Corp.
IPO dateJan 8, 2021
Employees724

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.08
P/FCF43.94
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -2.6%
Net -2.6%
FCF 2.5%
ROE / ROIC -16.7% · —

Financial Health

Current ratio1.33
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$111.44M

Cash Flow · TTM

Operating CF $57.25M
Capex −$2.71M
Free cash flow $54.54M
Buybacks $1.00K
Dividends paid
Shareholder yield 0.0%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

2.6
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings